Synaptive Medical Inc.

Based in Canada, Synaptive Medical Inc. develops advanced medical devices and technologies that enhance surgical, imaging, and data management processes in healthcare settings. Founded in 2012 in Toronto, Canada, Synaptive Medical Inc. specializes in innovative medical technologies.

The company has raised USD 50. 00 mn through multiple funding rounds, including a recent GRANT of USD 0. 90 mn from the Government of Ontario on August 2, 2023. The founders, Gal Sela and Wes Hodges, played pivotal roles in establishing the company, which has been involved in 15 deals to date.

Synaptive Medical specializes in advanced medical devices and technology aimed at enhancing surgical, imaging, and data management processes within healthcare settings. The company's core product offerings include the Synaptive Integrated Suite, which is an interdisciplinary platform that integrates high-quality information and automation throughout clinical interventions. Key components include Modus X, a robotic exoscopy system with advanced 4K 3D optics and fluorescence visualization; Modus Plan, which enables automatic tractography segmentation for rapid access to patient-specific neural bundles; and Modus Nav, designed for precise navigation during neurosurgical procedures using intraoperative tractography. Additionally, Synaptive MRI offers point-of-care MRI solutions to improve accessibility for patients, serving hospitals and surgical centers across North America, Europe, and select markets in Asia.

Synaptive Medical generates revenue through direct sales of its proprietary medical technologies to healthcare institutions and surgical facilities. The company engages in B2B transactions, offering its products under various pricing structures tailored to the needs of healthcare providers. Flagship products such as Modus X and Synaptive MRI are sold through direct contracts or partnership agreements, enabling hospitals to integrate these advanced solutions into their operational workflows. The revenue model may also involve ongoing support services and software updates, providing additional value to clients.

In August 2023, Synaptive Medical Inc. secured USD 900,000 of grant funding from the Government of Ontario, which will be utilized to expand its business and increase market reach. The company plans to introduce new products and services, aiming to penetrate new geographic markets, although specific details on upcoming launches or target regions have not been disclosed. The funding will support these initiatives, aiding in the enhancement of operational capabilities and product offerings.